Evidence map›Paper›PMID 32375049›Full record

ArticleCell reports2020

Variation of Human Neural Stem Cells Generating Organizer States In Vitro before Committing to Cortical Excitatory or Inhibitory Neuronal Fates.

Nicola Micali, Suel-Kee Kim, Marcelo Diaz-Bustamante, Genevieve Stein-O'Brien, Seungmae Seo, Joo-Heon Shin, Brian G Rash, Shaojie Ma, Yanhong Wang, Nicolas A Olivares and 13 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. ERK signaling expands mammalian cortical radial glial cells and extends the neurogenic period.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 1 country.

Nicola MicaliLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA; Department of Neuroscience, Yale School of Medicine, New Haven, CT 06520, USA. Electronic address: nicola.micali@yale.edu.
Suel-Kee KimLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA; Department of Neuroscience, Yale School of Medicine, New Haven, CT 06520, USA.
Marcelo Diaz-BustamanteLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA.
Genevieve Stein-O'BrienLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Seungmae SeoLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA.
Joo-Heon ShinLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA.
Brian G RashDepartment of Neuroscience, Yale School of Medicine, New Haven, CT 06520, USA.
Shaojie MaDepartments of Comparative Medicine, Genetics, and Psychiatry, Yale School of Medicine, New Haven, CT 06520, USA.
Yanhong WangLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA.
Nicolas A OlivaresLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA.
Jon I ArellanoDepartment of Neuroscience, Yale School of Medicine, New Haven, CT 06520, USA.
Kristen R MaynardLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA.
Elana J FertigDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Department of Applied Mathematics and Statistics, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Alan J CrossAstraZeneca Neuroscience, IMED Biotech Unit, R&D, Boston, MA 024515, USA.
Roland W BürliAstraZeneca Neuroscience, IMED Biotech Unit, R&D, Boston, MA 024515, USA.
Nicholas J BrandonAstraZeneca Neuroscience, IMED Biotech Unit, R&D, Boston, MA 024515, USA.
Daniel R WeinbergerLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Department of Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Joshua G ChenowethLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA.
Daniel J HoeppnerLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA; Astellas Research Institute of America, 3565 General Atomics Ct., Ste. 200, San Diego, CA 92121, USA.
Nenad SestanDepartment of Neuroscience, Yale School of Medicine, New Haven, CT 06520, USA; Departments of Comparative Medicine, Genetics, and Psychiatry, Yale School of Medicine, New Haven, CT 06520, USA; Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06520, USA.
Pasko RakicDepartment of Neuroscience, Yale School of Medicine, New Haven, CT 06520, USA; Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06520, USA. Electronic address: pasko.rakic@yale.edu.
Carlo ColantuoniLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Electronic address: ccolantu@jhmi.edu.
Ronald D McKayLieber Institute for Brain Development, 855 North Wolfe St., Baltimore, MD 21205, USA. Electronic address: ronald.mckay@libd.org.
Lieber Institute for Brain Development · USYale University · USAstraZeneca (United States) · USJohns Hopkins University · USGeneral Atomics (United States) · USJohns Hopkins Hospital · USJohns Hopkins Medicine · US

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6M
Origin of Cortical Species-specific Distinctions.R01DA023999 · NIDA · YALE UNIVERSITY · PI RAKIC, PASKO · 2008 to 2019
$7.9M
Functional Genomics of Human Brain DevelopmentP50MH106934 · NIMH · YALE UNIVERSITY · PI SESTAN, NENAD · 2014 to 2019
$7.9M
PRENATAL DEVELOPMENT OF THE VISUAL SYSTEMR01EY002593 · NEI · YALE UNIVERSITY · PI ARELLANO, JUAN I, RAKIC, PASKO · 1985 to 2018
$6.5M
1/2 Cell Type and Region-Specific Regulatory Networks in Human Brain Development and DisordersU01MH116488 · NIMH · YALE UNIVERSITY · PI SESTAN, NENAD · 2018 to 2022
$6.5M
Origin of Cortical Species-specific DistinctionsR37DA023999 · NIDA · YALE UNIVERSITY · PI PASKO RAKIC · 2020 to 2026
$5.6M
Yale Macaque Brain ResourceR01MH113257 · NIMH · YALE UNIVERSITY · PI Alvaro Duque · 2017 to 2026
$4.3M
2/2 Somatic mosaicism and autism spectrum disorderU01MH106874 · NIMH · YALE UNIVERSITY · PI SESTAN, NENAD · 2015 to 2019
$4.0M
1/3 Integrative Genomic Analysis of Human Brain Development and AutismR01MH110926 · NIMH · YALE UNIVERSITY · PI SESTAN, NENAD · 2016 to 2019
$3.2M
Integrating bioinformatics into multiscale models for hepatocellular carcinomaU01CA212007 · NCI · JOHNS HOPKINS UNIVERSITY · PI EWALD, ANDREW JOSEF, FERTIG, ELANA · 2018 to 2022
$3.2M
Dynamical Models of Cetuximab Resistance in HNSCC Based on Serial Genomics DataR01CA177669 · NCI · JOHNS HOPKINS UNIVERSITY · PI FERTIG, ELANA · 2014 to 2019
$1.8M
3/3 Multidimensional investigation of the etiology of autism spectrum disorderR01MH109904 · NIMH · YALE UNIVERSITY · PI SESTAN, NENAD · 2016 to 2018
$816k
NCI NIH HHS P30 CA006973NCI NIH HHS R01 CA177669NCI NIH HHS U01 CA212007NEI NIH HHS R01 EY002593NIDA NIH HHS R01 DA023999NIDA NIH HHS R37 DA023999NIMH NIH HHS P50 MH106934NIMH NIH HHS R01 MH109904NIMH NIH HHS R01 MH110926NIMH NIH HHS R01 MH113257NIMH NIH HHS U01 MH106874NIMH NIH HHS U01 MH116488
6 · The paper itself

Abstract

Better understanding of the progression of neural stem cells (NSCs) in the developing cerebral cortex is important for modeling neurogenesis and defining the pathogenesis of neuropsychiatric disorders. Here, we use RNA sequencing, cell imaging, and lineage tracing of mouse and human in vitro NSCs and monkey brain sections to model the generation of cortical neuronal fates. We show that conserved signaling mechanisms regulate the acute transition from proliferative NSCs to committed glutamatergic excitatory neurons. As human telencephalic NSCs develop from pluripotency in vitro, they transition through organizer states that spatially pattern the cortex before generating glutamatergic precursor fates. NSCs derived from multiple human pluripotent lines vary in these early patterning states, leading differentially to dorsal or ventral telencephalic fates. This work furthers systematic analyses of the earliest patterning events that generate the major neuronal trajectories of the human telencephalon.

Indexed as

Cell DifferentiationCells, CulturedEmbryonic Stem CellsHumansInduced Pluripotent Stem CellsNeural Stem CellsNeurogenesisNeuronsSignal TransductionBMPbrain organizerEGFRFGF2glutamatergic neuronshuman iPSC variationinhibitory neuronsneural stem cellneural transcriptional dynamicsneurogenesisneuronal trajectory variationpatterning of the cortex

Identifiers

PMID32375049
PMCPMC7357345
OpenAlexW3021606299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.